Article Information
History
- September 8, 2020.
Article Versions
- Version 1 (June 19, 2020 - 04:36).
- Version 2 (June 28, 2020 - 18:06).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Miroslava Cuperlovic-Culf1,*,
- Emma L. Cunningham2,
- Anu Surendra1,
- Xiaobei Pan3,
- Steffany A.L. Bennett4,
- Mijin Jung3,
- Bernadette McGuiness2,
- Anthony Peter Passmore2,
- Danny McAuley5,
- David Beverland6 and
- Brian D. Green3,*
- 1National Research Council of Canada, Digital Technologies Research Centre, Ottawa, Canada
- 2Centre for Public Health, Queen’s University Belfast, Block B, Institute of Clinical Sciences, Royal Victoria Hospital site, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland
- 3Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast, 8 Malone Road, Belfast, BT9 5BN, Northern Ireland
- 4Neural Regeneration Laboratory, Ottawa Institute of Systems Biology, Brain and Mind Research Institute, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada
- 5Centre for Experimental Medicine, Queen’s University Belfast, Wellcome-Wolfson Institute for Experimental Medicine, 97 Lisburn Road, Belfast, BT9 7BL
- 6Outcomes Assessment Unit, Musgrave Park Hospital, Stockman’s Lane, Belfast, BT9 7JB, Northern Ireland
- ↵*
Correspondence: Miroslava Cuperlovic-Culf and Brian D. Green Email:
miroslava.cuperlovic-culf{at}nrc-cnrc.gc.ca; b.green{at}qub.ac.uk
Posted September 08, 2020.
Potential involvement of monoamine oxidase activity in delirium onset and SARS-COV2 infection
